1. Home
  2. SOUN vs ACLX Comparison

SOUN vs ACLX Comparison

Compare SOUN & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SOUN
  • ACLX
  • Stock Information
  • Founded
  • SOUN 2005
  • ACLX 2015
  • Country
  • SOUN United States
  • ACLX United States
  • Employees
  • SOUN N/A
  • ACLX N/A
  • Industry
  • SOUN EDP Services
  • ACLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • SOUN Technology
  • ACLX Health Care
  • Exchange
  • SOUN Nasdaq
  • ACLX Nasdaq
  • Market Cap
  • SOUN 5.1B
  • ACLX 3.4B
  • IPO Year
  • SOUN N/A
  • ACLX 2022
  • Fundamental
  • Price
  • SOUN $15.71
  • ACLX $67.72
  • Analyst Decision
  • SOUN Buy
  • ACLX Strong Buy
  • Analyst Count
  • SOUN 6
  • ACLX 14
  • Target Price
  • SOUN $13.25
  • ACLX $107.67
  • AVG Volume (30 Days)
  • SOUN 56.6M
  • ACLX 726.9K
  • Earning Date
  • SOUN 02-27-2025
  • ACLX 02-26-2025
  • Dividend Yield
  • SOUN N/A
  • ACLX N/A
  • EPS Growth
  • SOUN N/A
  • ACLX N/A
  • EPS
  • SOUN N/A
  • ACLX N/A
  • Revenue
  • SOUN $67,297,000.00
  • ACLX $155,818,000.00
  • Revenue This Year
  • SOUN $86.49
  • ACLX $12.58
  • Revenue Next Year
  • SOUN $97.20
  • ACLX N/A
  • P/E Ratio
  • SOUN N/A
  • ACLX N/A
  • Revenue Growth
  • SOUN 76.05
  • ACLX 230.33
  • 52 Week Low
  • SOUN $1.62
  • ACLX $47.88
  • 52 Week High
  • SOUN $24.98
  • ACLX $107.37
  • Technical
  • Relative Strength Index (RSI)
  • SOUN 51.88
  • ACLX 44.93
  • Support Level
  • SOUN $13.05
  • ACLX $63.38
  • Resistance Level
  • SOUN $15.23
  • ACLX $70.24
  • Average True Range (ATR)
  • SOUN 1.51
  • ACLX 2.95
  • MACD
  • SOUN -0.12
  • ACLX 0.74
  • Stochastic Oscillator
  • SOUN 60.73
  • ACLX 70.21

About SOUN SoundHound AI Inc

SoundHound AI Inc is an innovator of conversational intelligence, offering an independent Voice AI platform that enables businesses across industries to deliver high-quality conversational experiences to customers.

About ACLX Arcellx Inc.

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.

Share on Social Networks: